Avicanna Inc (AVCN) - Total Liabilities
Based on the latest financial reports, Avicanna Inc (AVCN) has total liabilities worth CA$9.29 Million CAD (≈ $6.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Avicanna Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Avicanna Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Avicanna Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Avicanna Inc total assets.
Avicanna Inc Competitors by Total Liabilities
The table below lists competitors of Avicanna Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WIN Metals Ltd
AU:WIN
|
Australia | AU$3.69 Million |
|
Loyal Textile Mills Limited
NSE:LOYALTEX
|
India | Rs3.22 Billion |
|
Vroom, Inc.
NASDAQ:VRMMQ
|
USA | $1.10 Billion |
|
Vesuvius PLC
LSE:VSVS
|
UK | GBX1.22 Billion |
|
Impact Minerals Ltd
AU:IPT
|
Australia | AU$690.13K |
|
Pan Entertainment Co. Ltd
KQ:068050
|
Korea | ₩56.31 Billion |
|
Turiya Bhd
KLSE:4359
|
Malaysia | RM35.15 Million |
|
Mustera Property Group Ltd
AU:MPX
|
Australia | AU$24.55 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Avicanna Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AVCN equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avicanna Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avicanna Inc (2016–2025)
The table below shows the annual total liabilities of Avicanna Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$9.86 Million ≈ $7.13 Million |
-5.00% |
| 2024-12-31 | CA$10.38 Million ≈ $7.51 Million |
-25.89% |
| 2023-12-31 | CA$14.00 Million ≈ $10.13 Million |
-1.14% |
| 2022-12-31 | CA$14.16 Million ≈ $10.24 Million |
-8.01% |
| 2021-12-31 | CA$15.39 Million ≈ $11.14 Million |
-5.25% |
| 2020-12-31 | CA$16.25 Million ≈ $11.75 Million |
+6.26% |
| 2019-12-31 | CA$15.29 Million ≈ $11.06 Million |
+748.74% |
| 2018-12-31 | CA$1.80 Million ≈ $1.30 Million |
+41.13% |
| 2017-12-31 | CA$1.28 Million ≈ $923.33K |
+939.73% |
| 2016-12-31 | CA$122.76K ≈ $88.80K |
-- |
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios … Read more